Prostate Cancer Therapeutics Drugs Market Report

Global Prostate Cancer Therapeutics Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Mar 17, 2021
  • PAGES：166
  • REPORT CODE：GMM628621
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Prostate Cancer Therapeutics Drugs is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Prostate Cancer Therapeutics Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Prostate Cancer Therapeutics Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Prostate Cancer Therapeutics Drugs Market Segmentations:

    By Players:

    • Bayer AG

    • Takeda Pharmaceutical Company Limited

    • Sanofi,

    • Genentech, Inc

    • Pfizer Inc

    • Teva Pharmaceutical Industries Ltd

    • AstraZeneca

    • Myovant Sciences Ltd

    • GlaxoSmithKline plc

    • Tolmar Pharmaceuticals, Inc

    • Novartis AG

    • Astellas Pharma US, Inc,

    • Johnson & Johnson Services, Inc,

    • AbbVie Inc,

    • Abbott

    • Bristol-Myers Squibb Company

    • Dendreon Pharmaceuticals LLC

    • Ferring BV

    • F Hoffmann-La Roche Ltd

    • Ipsen Pharma,

    By Types:

    • Hormone Therapy

    • Chemotherapy

    • Biologic Therapy

    • Targeted Therapy

    • Other

    By End-User:

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Sales

    • Other

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prostate Cancer Therapeutics Drugs Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Hormone Therapy from 2014 to 2026

      • 1.3.2 Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Chemotherapy from 2014 to 2026

      • 1.3.3 Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Biologic Therapy from 2014 to 2026

      • 1.3.4 Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Targeted Therapy from 2014 to 2026

      • 1.3.5 Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026

      • 1.4.2 Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Retail Pharmacy from 2014 to 2026

      • 1.4.3 Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Online Sales from 2014 to 2026

      • 1.4.4 Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Prostate Cancer Therapeutics Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Prostate Cancer Therapeutics Drugs Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Prostate Cancer Therapeutics Drugs by Major Types

      • 3.4.1 Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Hormone Therapy

      • 3.4.2 Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Chemotherapy

      • 3.4.3 Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Biologic Therapy

      • 3.4.4 Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Targeted Therapy

      • 3.4.5 Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Other

    4 Segmentation of Prostate Cancer Therapeutics Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Prostate Cancer Therapeutics Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Prostate Cancer Therapeutics Drugs in Hospital Pharmacy

      • 4.4.2 Market Size and Growth Rate of Prostate Cancer Therapeutics Drugs in Retail Pharmacy

      • 4.4.3 Market Size and Growth Rate of Prostate Cancer Therapeutics Drugs in Online Sales

      • 4.4.4 Market Size and Growth Rate of Prostate Cancer Therapeutics Drugs in Other

    5 Market Analysis by Major Regions

    • 5.1 Global Prostate Cancer Therapeutics Drugs Production Analysis by Major Regions

    • 5.2 Global Prostate Cancer Therapeutics Drugs Consumption Analysis by Major Regions

    • 5.3 Global Prostate Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Prostate Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Prostate Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Prostate Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

    6 Product Commodity of Prostate Cancer Therapeutics Drugs Market in Major Countries

    • 6.1 Top 5 Export Countries in Prostate Cancer Therapeutics Drugs market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Prostate Cancer Therapeutics Drugs market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Prostate Cancer Therapeutics Drugs market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Prostate Cancer Therapeutics Drugs market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Prostate Cancer Therapeutics Drugs market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Prostate Cancer Therapeutics Drugs market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Prostate Cancer Therapeutics Drugs Landscape Analysis

    • 7.1 North America Prostate Cancer Therapeutics Drugs Landscape Analysis by Major Types

    • 7.2 North America Prostate Cancer Therapeutics Drugs Landscape Analysis by Major End-Users

    • 7.3 North America Prostate Cancer Therapeutics Drugs Landscape Analysis by Major Countries

      • 7.3.1 United States Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 7.3.2 Canada Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 7.3.3 Mexico Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

    8 Europe Prostate Cancer Therapeutics Drugs Landscape Analysis

    • 8.1 Europe Prostate Cancer Therapeutics Drugs Landscape Analysis by Major Types

    • 8.2 Europe Prostate Cancer Therapeutics Drugs Landscape Analysis by Major End-Users

    • 8.3 Europe Prostate Cancer Therapeutics Drugs Landscape Analysis by Major Countries

      • 8.3.1 Germany Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 8.3.2 UK Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 8.3.3 France Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 8.3.4 Italy Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 8.3.6 Spain Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 8.3.7 Belgium Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 8.3.8 Poland Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 8.3.9 Russia Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 8.3.10 Turkey Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

    9 Asia Pacific Prostate Cancer Therapeutics Drugs Landscape Analysis

    • 9.1 Asia Pacific Prostate Cancer Therapeutics Drugs Landscape Analysis by Major Types

    • 9.2 Asia Pacific Prostate Cancer Therapeutics Drugs Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Prostate Cancer Therapeutics Drugs Landscape Analysis by Major Countries

      • 9.3.1 China Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 9.3.2 Japan Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 9.3.4 India Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 9.3.6 South Korea Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 10.3.2 Brazil Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 10.3.3 Nigeria Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

      • 10.3.4 South Africa Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate 

      • 10.3.5 Argentina Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Bayer AG

      • 11.1.1 Bayer AG Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Takeda Pharmaceutical Company Limited

      • 11.2.1 Takeda Pharmaceutical Company Limited Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Sanofi,

      • 11.3.1 Sanofi, Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Genentech, Inc

      • 11.4.1 Genentech, Inc Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Pfizer Inc

      • 11.5.1 Pfizer Inc Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Teva Pharmaceutical Industries Ltd

      • 11.6.1 Teva Pharmaceutical Industries Ltd Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 AstraZeneca

      • 11.7.1 AstraZeneca Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Myovant Sciences Ltd

      • 11.8.1 Myovant Sciences Ltd Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 GlaxoSmithKline plc

      • 11.9.1 GlaxoSmithKline plc Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Tolmar Pharmaceuticals, Inc

      • 11.10.1 Tolmar Pharmaceuticals, Inc Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Novartis AG

      • 11.11.1 Novartis AG Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Astellas Pharma US, Inc,

      • 11.12.1 Astellas Pharma US, Inc, Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Johnson & Johnson Services, Inc,

      • 11.13.1 Johnson & Johnson Services, Inc, Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 AbbVie Inc,

      • 11.14.1 AbbVie Inc, Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Abbott

      • 11.15.1 Abbott Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Bristol-Myers Squibb Company

      • 11.16.1 Bristol-Myers Squibb Company Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Dendreon Pharmaceuticals LLC

      • 11.17.1 Dendreon Pharmaceuticals LLC Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Ferring BV

      • 11.18.1 Ferring BV Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 F Hoffmann-La Roche Ltd

      • 11.19.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Ipsen Pharma,

      • 11.20.1 Ipsen Pharma, Company Profile and Recent Development

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 78 Figures and 133 Tables)

    • Figure Product Picture

    • Figure Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Hormone Therapy from 2014 to 2026

    • Figure Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Chemotherapy from 2014 to 2026

    • Figure Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Biologic Therapy from 2014 to 2026

    • Figure Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Targeted Therapy from 2014 to 2026

    • Figure Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026

    • Figure Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Retail Pharmacy from 2014 to 2026

    • Figure Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Online Sales from 2014 to 2026

    • Figure Global Prostate Cancer Therapeutics Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Prostate Cancer Therapeutics Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Prostate Cancer Therapeutics Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Prostate Cancer Therapeutics Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Prostate Cancer Therapeutics Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Prostate Cancer Therapeutics Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Hormone Therapy

    • Figure Market Size and Growth Rate of Chemotherapy

    • Figure Market Size and Growth Rate of Biologic Therapy

    • Figure Market Size and Growth Rate of Targeted Therapy

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Prostate Cancer Therapeutics Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Prostate Cancer Therapeutics Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital Pharmacy

    • Figure Market Size and Growth Rate of Retail Pharmacy

    • Figure Market Size and Growth Rate of Online Sales

    • Figure Market Size and Growth Rate of Other

    • Table Global Prostate Cancer Therapeutics Drugs Production by Major Regions

    • Table Global Prostate Cancer Therapeutics Drugs Production Share by Major Regions

    • Figure Global Prostate Cancer Therapeutics Drugs Production Share by Major Regions in 2014

    • Figure Global Prostate Cancer Therapeutics Drugs Production Share by Major Regions in 2018

    • Figure Global Prostate Cancer Therapeutics Drugs Production Share by Major Regions in 2026

    • Table Global Prostate Cancer Therapeutics Drugs Consumption by Major Regions

    • Table Global Prostate Cancer Therapeutics Drugs Consumption Share by Major Regions

    • Figure Global Prostate Cancer Therapeutics Drugs Consumption Share by Major Regions in 2014

    • Figure Global Prostate Cancer Therapeutics Drugs Consumption Share by Major Regions in 2018

    • Figure Global Prostate Cancer Therapeutics Drugs Consumption Share by Major Regions in 2026

    • Table North America Prostate Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

    • Table Europe Prostate Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Prostate Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Prostate Cancer Therapeutics Drugs market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Prostate Cancer Therapeutics Drugs market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Prostate Cancer Therapeutics Drugs market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Prostate Cancer Therapeutics Drugs market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Prostate Cancer Therapeutics Drugs Consumption by Types from 2014 to 2026

    • Table North America Prostate Cancer Therapeutics Drugs Consumption Share by Types from 2014 to 2026

    • Figure North America Prostate Cancer Therapeutics Drugs Consumption Share by Types in 2014

    • Figure North America Prostate Cancer Therapeutics Drugs Consumption Share by Types in 2018

    • Figure North America Prostate Cancer Therapeutics Drugs Consumption Share by Types in 2026

    • Table North America Prostate Cancer Therapeutics Drugs Consumption by End-Users from 2014 to 2026

    • Table North America Prostate Cancer Therapeutics Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure North America Prostate Cancer Therapeutics Drugs Consumption Share by End-Users in 2014

    • Figure North America Prostate Cancer Therapeutics Drugs Consumption Share by End-Users in 2018

    • Figure North America Prostate Cancer Therapeutics Drugs Consumption Share by End-Users in 2026

    • Table North America Prostate Cancer Therapeutics Drugs Consumption by Major Countries from 2014 to 2026

    • Table North America Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries in 2014

    • Figure North America Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries in 2018

    • Figure North America Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries in 2026

    • Figure United States Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Prostate Cancer Therapeutics Drugs Consumption by Types from 2014 to 2026

    • Table Europe Prostate Cancer Therapeutics Drugs Consumption Share by Types from 2014 to 2026

    • Figure Europe Prostate Cancer Therapeutics Drugs Consumption Share by Types in 2014

    • Figure Europe Prostate Cancer Therapeutics Drugs Consumption Share by Types in 2018

    • Figure Europe Prostate Cancer Therapeutics Drugs Consumption Share by Types in 2026

    • Table Europe Prostate Cancer Therapeutics Drugs Consumption by End-Users from 2014 to 2026

    • Table Europe Prostate Cancer Therapeutics Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Prostate Cancer Therapeutics Drugs Consumption Share by End-Users in 2014

    • Figure Europe Prostate Cancer Therapeutics Drugs Consumption Share by End-Users in 2018

    • Figure Europe Prostate Cancer Therapeutics Drugs Consumption Share by End-Users in 2026

    • Table Europe Prostate Cancer Therapeutics Drugs Consumption by Major Countries from 2014 to 2026

    • Table Europe Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries in 2014

    • Figure Europe Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries in 2018

    • Figure Europe Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries in 2026

    • Figure Germany Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure France Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Prostate Cancer Therapeutics Drugs Consumption by Types from 2014 to 2026

    • Table Asia Pacific Prostate Cancer Therapeutics Drugs Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Prostate Cancer Therapeutics Drugs Consumption Share by Types in 2014

    • Figure Asia Pacific Prostate Cancer Therapeutics Drugs Consumption Share by Types in 2018

    • Figure Asia Pacific Prostate Cancer Therapeutics Drugs Consumption Share by Types in 2026

    • Table Asia Pacific Prostate Cancer Therapeutics Drugs Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Prostate Cancer Therapeutics Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Prostate Cancer Therapeutics Drugs Consumption Share by End-Users in 2014

    • Figure Asia Pacific Prostate Cancer Therapeutics Drugs Consumption Share by End-Users in 2018

    • Figure Asia Pacific Prostate Cancer Therapeutics Drugs Consumption Share by End-Users in 2026

    • Table Asia Pacific Prostate Cancer Therapeutics Drugs Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries in 2026

    • Figure China Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandProstate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure India Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Prostate Cancer Therapeutics Drugs Consumption Share by Major Countries in 2026

    • Figure GCC Countries Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Prostate Cancer Therapeutics Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG

    • Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited

    • Table Product and Service Introduction of Takeda Pharmaceutical Company Limited

    • Table Company Profile and Development Status of Sanofi,

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi,

    • Figure Sales and Growth Rate Analysis of Sanofi,

    • Figure Revenue and Market Share Analysis of Sanofi,

    • Table Product and Service Introduction of Sanofi,

    • Table Company Profile and Development Status of Genentech, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech, Inc

    • Figure Sales and Growth Rate Analysis of Genentech, Inc

    • Figure Revenue and Market Share Analysis of Genentech, Inc

    • Table Product and Service Introduction of Genentech, Inc

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd

    • Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Myovant Sciences Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myovant Sciences Ltd

    • Figure Sales and Growth Rate Analysis of Myovant Sciences Ltd

    • Figure Revenue and Market Share Analysis of Myovant Sciences Ltd

    • Table Product and Service Introduction of Myovant Sciences Ltd

    • Table Company Profile and Development Status of GlaxoSmithKline plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

    • Table Product and Service Introduction of GlaxoSmithKline plc

    • Table Company Profile and Development Status of Tolmar Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tolmar Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Tolmar Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Tolmar Pharmaceuticals, Inc

    • Table Product and Service Introduction of Tolmar Pharmaceuticals, Inc

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Astellas Pharma US, Inc,

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma US, Inc,

    • Figure Sales and Growth Rate Analysis of Astellas Pharma US, Inc,

    • Figure Revenue and Market Share Analysis of Astellas Pharma US, Inc,

    • Table Product and Service Introduction of Astellas Pharma US, Inc,

    • Table Company Profile and Development Status of Johnson & Johnson Services, Inc,

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson Services, Inc,

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson Services, Inc,

    • Figure Revenue and Market Share Analysis of Johnson & Johnson Services, Inc,

    • Table Product and Service Introduction of Johnson & Johnson Services, Inc,

    • Table Company Profile and Development Status of AbbVie Inc,

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie Inc,

    • Figure Sales and Growth Rate Analysis of AbbVie Inc,

    • Figure Revenue and Market Share Analysis of AbbVie Inc,

    • Table Product and Service Introduction of AbbVie Inc,

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company

    • Table Product and Service Introduction of Bristol-Myers Squibb Company

    • Table Company Profile and Development Status of Dendreon Pharmaceuticals LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dendreon Pharmaceuticals LLC

    • Figure Sales and Growth Rate Analysis of Dendreon Pharmaceuticals LLC

    • Figure Revenue and Market Share Analysis of Dendreon Pharmaceuticals LLC

    • Table Product and Service Introduction of Dendreon Pharmaceuticals LLC

    • Table Company Profile and Development Status of Ferring BV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring BV

    • Figure Sales and Growth Rate Analysis of Ferring BV

    • Figure Revenue and Market Share Analysis of Ferring BV

    • Table Product and Service Introduction of Ferring BV

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of Ipsen Pharma,

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ipsen Pharma,

    • Figure Sales and Growth Rate Analysis of Ipsen Pharma,

    • Figure Revenue and Market Share Analysis of Ipsen Pharma,

    • Table Product and Service Introduction of Ipsen Pharma,


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US